Cephalexin 500 mg Every 12 Hours is NOT Underdosing for Uncomplicated Cystitis
Cephalexin 500 mg orally every 12 hours is the FDA-approved dosing regimen for uncomplicated cystitis and is explicitly supported by both the FDA label and current guidelines 1.
FDA-Approved Dosing
The FDA label for cephalexin clearly states: "For the following infections, a dosage of 500 mg may be administered every 12 hours: streptococcal pharyngitis, skin and skin structure infections, and uncomplicated cystitis in patients over 15 years of age" 1. This is the standard, approved dosing—not underdosing.
The FDA label also specifies that cystitis therapy should be continued for 7 to 14 days 1, which is longer than many first-line agents but reflects the lack of robust evidence for shorter β-lactam courses in cystitis.
Guideline Support
The 2024 JAMA guidelines acknowledge that β-lactams (including first-generation cephalosporins like cephalexin) are reasonable treatment options for uncomplicated cystitis, though they note insufficient evidence to provide clear recommendations on optimal duration 2. The 2026 European guidelines list cefadroxil (a related first-generation cephalosporin) at 500 mg twice daily for 3 days as an alternative agent 3, supporting the twice-daily dosing paradigm for this drug class.
Why This Dosing Works
Cephalexin achieves urinary concentrations of 500-1000 mcg/mL following 250-500 mg oral doses—"many times greater than the minimum inhibitory concentration for the usual urinary tract pathogens" 4. The drug is rapidly and completely absorbed from the upper intestine, with 70-100% of the dose appearing in urine within 6-8 hours 4.
Important Caveats
Cephalexin is not a first-line agent for uncomplicated cystitis. First-line options include nitrofurantoin, fosfomycin, pivmecillinam, or nitroxoline 3, 5. Cephalexin should be reserved for situations where first-line agents cannot be used due to allergy, intolerance, or contraindications.
Recent evidence suggests cephalexin may be superior to other oral cephalosporins like cefdinir for UTI treatment. A 2025 study found cefdinir had nearly twice the treatment failure rate compared to cephalexin (23.4% vs 12.5%), with patients failing cefdinir more likely to develop cephalosporin-resistant organisms 6.
The 500 mg every 12 hours dosing is correct and should not be increased to every 6 hours or higher doses unless treating more severe infections or less susceptible organisms 1.